Jeffrey Ubben is handing over the reins — at least when it comes to investing — at his $16 billion hedge fund ValueAct. Ubben, 55, will continue to serve as CEO, but ValueAct’s current president Mason Morfit will become chief investment officer in July, according to a letter ValueAct sent to investors Monday. Morfit, who...